PRME
Prime Medicine, Inc.
3.10$
+4.7%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -170.7% | -11,456.3% | -120.4% | -12,398.1% | 744.2% | -3,360.2% | -3,714.1% | -2,860.3% | -4,445.8% | -4,989.5% | -3,556.8% | -3,831.4% | |
| – | 4.9% | 222.5% | 4.1% | 745.5% | 78.7% | 105.6% | 130.3% | 153.6% | 61.3% | 216.8% | 154.7% | 148.2% | |
| – | 17.2% | 881.4% | 21.4% | 3,266.5% | 272.1% | 390.7% | 567.3% | 1,040.6% | 538.8% | 542.5% | 421.6% | 657.3% | |
| – | 56.2% | -5,094.9% | 23.2% | 1,711.0% | 2,238.2% | -526.3% | 49.1% | 49.7% | 137.9% | -292.1% | -705.5% | -217.9% | |
| – | 7.2% | 393.2% | 5.0% | 611.0% | 82.0% | 166.6% | 141.0% | 20.2% | 34.6% | 25.0% | 4.0% | 19.6% | |
| – | 160.7% | -6,266.0% | 18.3% | 24,087.1% | 2,210.4% | -3,283.5% | 248.5% | -7,520.2% | 3,380.7% | 5,069.0% | 2,082.3% | 89.1% | |
| – | 0.8% | 26,620.5% | 0.1% | 18,427.3% | 0.0% | 412.7% | 17.7% | 11,816.6% | 67.1% | 45.9% | 31.3% | 3,586.3% | |
| – | -9.3% | 8,898.1% | -102.1% | 30,116.3% | 2,954.6% | -6,231.0% | -3,447.9% | 1,436.1% | -998.1% | 125.5% | -1,443.2% | -156.0% | |
| – | -177.9% | -11,849.6% | -125.5% | -13,009.1% | 662.1% | -3,526.8% | -3,855.1% | -2,880.5% | -4,480.4% | -5,014.5% | -3,560.8% | -3,850.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.